Survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients
Sunday, September 27, 2015 - 20:00
in Health & Medicine
For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma, a patient population for whom treatment options are currently limited.